Case Study: StrateLaunch Support

Situation

A small biotech company was preparing to launch a new therapy for a rare neurodegenerative disease without an internal HEOR team

Objective

To become their HEOR partner and develop key launch deliverables supporting the value of the product

Solution

StrateLaunch—developed a budget impact model and AMCP Dossier, rapidly generated and published evidence on the prevalence of disease in the US & analyzed real-world data from an expanded access program

Impact

Maximized HEOR evidence generation and communication activities within launch budget and timelines